{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:17:57Z","timestamp":1791386277783,"version":"4.3.3"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005334","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T17:34:17Z","timestamp":1461692057000},"page":"e1005334","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Correlates of Protection against Norovirus Infection and Disease\u2014Where Are We Now, Where Do We Go?"],"prefix":"10.1371","volume":"12","author":[{"given":"Sasirekha","family":"Ramani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MOG.0000000000000022","article-title":"Epidemiology of human noroviruses and updates on vaccine development","volume":"30","author":"S Ramani","year":"2014","journal-title":"Current opinion in gastroenterology"},{"issue":"49","key":"ref2","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.vaccine.2012.09.040","article-title":"The potential economic value of a human norovirus vaccine for the United States","volume":"30","author":"SM Bartsch","year":"2012","journal-title":"Vaccine"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"RL Atmar","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM197707142970204","article-title":"Clinical immunity in acute gastroenteritis caused by Norwalk agent","volume":"297","author":"TA Parrino","year":"1977","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/339883","article-title":"Norwalk virus infection and disease is associated with ABO histo-blood group type","volume":"185","author":"AM Hutson","year":"2002","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/gast.2002.33661","article-title":"Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals","volume":"122","author":"S Marionneau","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm860","article-title":"Human susceptibility and resistance to Norwalk virus infection","volume":"9","author":"L Lindesmith","year":"2003","journal-title":"Nature medicine"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/JCM.01535-14","article-title":"Advances in laboratory methods for detection and typing of norovirus","volume":"53","author":"J Vinje","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1128\/JVI.79.11.6714-6722.2005","article-title":"Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns","volume":"79","author":"P Huang","year":"2005","journal-title":"Journal of virology"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"A Reeck","year":"2010","journal-title":"The Journal of infectious diseases"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological Correlates of Protection against a GII.4 Norovirus","volume":"22","author":"RL Atmar","year":"2015","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate-Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults","volume":"210","author":"JJ Treanor","year":"2014","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"SE Ohmit","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/jiv053","article-title":"Mucosal and Cellular Immune Responses to Norwalk Virus","volume":"212","author":"S Ramani","year":"2015","journal-title":"The Journal of infectious diseases"},{"issue":"6219","key":"ref15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"TJ Nice","year":"2015","journal-title":"Science"},{"issue":"6219","key":"ref16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.1258025","article-title":"Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection","volume":"347","author":"MT Baldridge","year":"2015","journal-title":"Science"},{"issue":"6210","key":"ref17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1126\/science.1257147","article-title":"Enteric bacteria promote human and mouse norovirus infection of B cells","volume":"346","author":"MK Jones","year":"2014","journal-title":"Science"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1908.130472","article-title":"Duration of immunity to norovirus gastroenteritis","volume":"19","author":"K Simmons","year":"2013","journal-title":"Emerging infectious diseases"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/CVI.00516-14","article-title":"Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity","volume":"22","author":"R Czako","year":"2015","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial","volume":"12","author":"LC Lindesmith","year":"2015","journal-title":"PLoS Med"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"e1002705","DOI":"10.1371\/journal.ppat.1002705","article-title":"Immunogenetic mechanisms driving norovirus GII.4 antigenic variation","volume":"8","author":"LC Lindesmith","year":"2012","journal-title":"PLoS Pathog"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ajic.2012.08.002","article-title":"Clinical characteristics of norovirus-associated deaths: a systematic literature review","volume":"41","author":"TK Trivedi","year":"2013","journal-title":"American journal of infection control"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.05592-11","article-title":"Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus","volume":"19","author":"R Czako","year":"2012","journal-title":"Clinical and vaccine immunology: CVI"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:41:10Z","timestamp":1589010070000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005334"}},"subtitle":[],"editor":[{"given":"Rebecca Ellis","family":"Dutch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005334","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]}}}